Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen
NCT04444843
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Kidney Transplant Recipients
Interventions
DRUG:
Mycophenolate Mofetil Capsules
Sponsor
First Affiliated Hospital Xi'an Jiaotong University